Alchemab Therapeutics names Ulrich Wendt chief business officer

Alchemab Therapeutics has appointed Ulrich Wendt, PhD MBA, as its new Chief Business Officer to lead business development and expand partnerships with biopharma and adjacent sectors, according to t

原文链接

阅读原文 →